163 filings
Page 5 of 9
8-K
pjjh6a7zx jo42v8
5 Aug 21
NGM Bio Provides Business Highlights and Reports Second Quarter 2021 Financial Results
4:17pm
8-K
pcs42muh csid
1 Jul 21
Entry into a Material Definitive Agreement
7:26am
8-K
lbf8j p0u
10 Jun 21
Submission of Matters to a Vote of Security Holders
5:27pm
8-K
editdtxsrvym kqs
24 May 21
NGM Bio Reports Topline Results from 24-Week Phase 2b ALPINE 2/3 Study of Aldafermin in NASH
7:09am
8-K
agt c5tnc94d
6 May 21
NGM Bio Provides Business Highlights and Reports First Quarter 2021 Financial Results
4:16pm
DEFA14A
68kllh
28 Apr 21
Additional proxy soliciting materials
4:38pm
8-K
qh2xxzfx
28 Apr 21
NGM Announces Nomination of Roger M. Perlmutter for Election to its Board of Directors
4:26pm
DEFA14A
f3ci01rmg 76kgk
28 Apr 21
Additional proxy soliciting materials
4:24pm
S-8
jzxd41sslghagmz4
15 Mar 21
Registration of securities for employees
4:53pm
8-K
bg06dq oi
15 Mar 21
Entry into a Material Definitive Agreement
4:50pm
8-K
r2k48zb2
4 Mar 21
NGM Bio Provides Business Highlights and Reports Fourth Quarter and Full Year 2020 Financial Results
4:14pm
8-K
rjcn3de
6 Jan 21
Results of Operations and Financial Condition
4:24pm
424B5
it1j hqo9e
6 Jan 21
Prospectus supplement for primary offering
4:23pm
424B5
zrcrld
4 Jan 21
Prospectus supplement for primary offering
4:10pm
8-K
zt7bj8i7ufcvmb
12 Nov 20
NGM Bio Provides Business Highlights and Reports Third Quarter 2020 Financial Results
4:32pm